These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2668148)

  • 1. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials.
    Dusheiko GM; Paterson AC; Pitcher L; Kassianides C; DiBisceglie AM; Song E; Kew MC
    J Hepatol; 1986; 3 Suppl 2():S199-207. PubMed ID: 3298408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
    Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
    BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M
    Gastroenterol Jpn; 1990 Feb; 25(1):70-7. PubMed ID: 2106467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of intrahepatic localization of hepatitis B core antigen in HBeAg positive patients with chronic active hepatitis B treated with interferon.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Iwai M; Kashima K; Sokawa Y
    Am J Gastroenterol; 1990 Jun; 85(6):660-4. PubMed ID: 2191593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
    Franco A; Barnaba V; Levrero M; Ruberti G; Van Dyke A; Bonavita MS; Balsano F
    J Hepatol; 1986; 3 Suppl 2():S239-43. PubMed ID: 3298412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant leukocyte interferon treatment of chronic hepatitis B.
    Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
    Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG; Karayiannis P; Thomas HC
    Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
    Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
    Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.